Signettx
1 known investors
Find your way into Signettx
Sign up to see every warm intro you have to Signettx
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Signettx team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Signet Therapeutics develops targeted cancer drugs using cancer organoid models combined with artificial intelligence. The company focuses on discovering novel therapies for cancers that currently lack effective treatment options.
Investors · 1
Frequently asked questions
- What does Signettx do?
- Signet Therapeutics develops targeted cancer drugs using cancer organoid models combined with artificial intelligence. The company focuses on discovering novel therapies for cancers that currently lack effective treatment options.
- Who are Signettx's investors?
- Signettx's investors include Blue Ocean Capital Group.